Skip to Main Content

Paper Details

Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients.
Ann Rheum Dis
167
2019
B cells, Patients, RA, Synovial biopsies, gene, joint, myeloid, myeloid cells, myeloid- and lymphoid-associated gene, osteoclast-targeting genes, patients, rheumatoid arthritis, stromal cells, synovial lymphoid-associated genes
Author NameAffiliation
Frances HumbyWilliam Harvey Research Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University of London
Myles J LewisWilliam Harvey Research Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University of London
Michael R BarnesWilliam Harvey Research Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University of London
Michael R BarnesWilliam Harvey Research Institute
Michele BombardieriWilliam Harvey Research Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University of London
Rebecca HandsWilliam Harvey Research Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University of London
Annette H M van der Helm-van MilLeiden University Medical Center
Christopher D BuckleyUniversity of Birmingham
Costantino PitzalisWilliam Harvey Research Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University of London
  • 1 - 9

Datasets

Release 1.2